In a Phase I study presented at AACR's annual meeting, 71 percent of patients who hadn't received a prior anti-HER2 ADC responded to the drug.

The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced ...

Zongertinib, an oral therapy shown to have strong responses in patients previously treated for HER2 -mutated non–small cell ...

Zongertinib, a HER2-targeted therapy made by Boehringer Ingelheim, demonstrated promising results in HER2-mutant lung cancer.

Scientists have discovered that a rare immune cell type in the lungs, called NAMs, plays a crucial role in surviving COVID-19 ...

Future research should focus on illuminating how different interstitial lung disease subtypes affect outcomes in AAV. Interstitial lung disease (ILD) patterns differ between patients with ...

tuberculosis, says Medha Singh, Ph.D., the study’s first author and a pediatric infectious diseases fellow in the school of medicine, promoting necrotic niches within the lung that prevent immune ...

Oncology, cardiology and endocrinology organizations have nutrition guidelines for disease prevention. Diet has a direct and indirect impact on lung health. SMART goals can help improve food choices.